Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement.

Autor:	Scadding GK; Royal National TNE Hospital and Department of Immunology, University College London, United Kingdom., Hellings PW; University Hospitals Leuven, Department of Otorhinolaryngology-Head and Neck Surgery, Leuven, Belgium.; Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Belgium.; Academic Medical Center, University of Amsterdam, Department of Otorhinolaryngology, Amsterdam, the Netherlands., Bachert C; Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Belgium.; Division of ENT Diseases, CLINTEC, Karolinska Institute, University of Stockholm, Sweden.; First Affiliated Hospital, Sun Yat-sen University, International Airway Research Center, Guangzhou, China., Bjermer L; Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund University, Sweden., Diamant Z; Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.; Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center of Groningen and QPS-NL, Groningen, the Netherlands., Gevaert P; Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Belgium., Kjeldsen A; Department of Otorhinolaryngology, Head and Neck Surgery, University of Southern Denmark, Odense, Denmark., Kleine-Tebbe J; Allergy & Asthma Center Westend, Outpatient & Clinical Research Center, Berlin, Germany., Klimek L; Wiesbaden Center for Rhinology and Allergology, Wiesbaden, Germany., Muraro A; Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy., Roberts G; David Hide Centre, St Mary's Hospital, Isle of Wight, and University of Southampton, Southampton, United Kingdom., Steinsvik A; Akershus University Hospital, Department of Otorhinolaryngology and Head and Neck surgery, Division of Surgery, Norway., Wagenmann M; Dept. of Otorhinolaryngology, Düsseldorf University Hospital, Germany., Wahn U; Charite, Berlin, Germany.
Jazyk:	angličtina
Zdroj:	The World Allergy Organization journal [World Allergy Organ J] 2020 May 16; Vol. 13 (5), pp. 100124. Date of Electronic Publication: 2020 May 16 (Print Publication: 2020).
DOI:	10.1016/j.waojou.2020.100124
Abstrakt:	Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT. (Crown Copyright © 2020 Published by Elsevier Inc. on behalf of World Allergy Organization.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu